HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fong, I. W. Articles by McKee, D. C. Search for Related Content PubMed PubMed Citation Articles by Fong, I. W. Articles by McKee, D. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 78, 908-913, Copyright © 1979 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The value of prophylactic antibiotics in aorat-coronary bypass operations: a double-blind randomized trial

IW Fong, CB Baker and DC McKee

Prospective and retrospective studies were performed to determine the efficacy of prophylactic antibiotics in preventing infections in patients undergoing arota-coronary bypass. One-hundred five patients were randomized in a double-blind fashion to receive either methicillin or saline-placebo for 3 days. The over-all infection rate was 26.7% with 48.9% in the control group and 8.6% in the methicillin group (p less than 0.001). Significant sternal wound infection developed in 21.3% of the control group and 0% of the methicillin group (p less than 0.01). Staphylococcus aureus was the predominant organism causing significant sternal infection (methicillin group versus control group, 5.2% and 21.3%; p less than 0.05). The length of postoperative stay in hospital and the number of days with fever was significantly greater in the control group than in the methicillin group (p less than 0.001). During the same period of time, 160 patients were studied retrospectively. Of these, 150 patients received cephalothin prophylaxis and 10 received methicillin. Comparison of the rates of infection in the cephalothin group to the total methicillin group (prospective and retrospective) showed no significant difference. The study clearly demonstrated that a short course of prophylactic antistaphlococcal penicillin or cephalosporin is justified in aorta- coronary bypass.

This article has been cited by other articles:

				R. Engelman, D. Shahian, R. Shemin, T. S. Guy, D. Bratzler, F. Edwards, M. Jacobs, H. Fernando, and C. Bridges The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part II: Antibiotic Choice Ann. Thorac. Surg., April 1, 2007; 83(4): 1569 - 1576. [Full Text] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				R. Finkelstein, G. Rabino, T. Mashiah, Y. Bar-El, Z. Adler, V. Kertzman, O. Cohen, and S. Milo Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 326 - 332. [Abstract] [Full Text] [PDF]

				R. Saginur, D. Croteau, and M. G. Bergeron Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1120 - 1130. [Abstract] [Full Text] [PDF]

				I. Kriaras, A. Michalopoulos, M. Turina, and S. Geroulanos Evolution of antimicrobial prophylaxis in cardiovascular surgery Eur. J. Cardiothorac. Surg., October 1, 2000; 18(4): 440 - 446. [Abstract] [Full Text] [PDF]

				U. Niederhauser, M. Vogt, P. Vogt, M. Genoni, A. Kunzli, and M. I. Turina CARDIAC SURGERY IN A HIGH-RISK GROUP OF PATIENTS: IS PROLONGED POSTOPERATIVE ANTIBIOTIC PROPHYLAXIS EFFECTIVE?. J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 162 - 168. [Abstract] [Full Text]

				D. L. Palmer, S. B. Pett, and B. F. Akl Bacterial Wound Colonization After Broad-Spectrum Versus Narrow-Spectrum Antibiotics Ann. Thorac. Surg., March 1, 1995; 59(3): 626 - 631. [Abstract] [Full Text]

				J. M. Rosenberg, J. A. Wahr, and K. A. Smith Effect of vancomycin infusion on cardiac function in patients scheduled for cardiac operation J. Thorac. Cardiovasc. Surg., March 1, 1995; 109(3): 561 - 564. [Abstract] [Full Text]

				R. Freeman and F. Gould Review article : Antibiotic prophylaxis for cardiac surgery Perfusion, January 1, 1986; 1(2): 75 - 79. [PDF]